Matthew B. Avison
About
Matthew B. Avison is a scholar working on Molecular Medicine, Endocrinology and Molecular Biology.
According to data from OpenAlex, Matthew B. Avison has authored 85 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Medicine, 39 papers in Endocrinology and 34 papers in Molecular Biology. Recurrent topics in Matthew B. Avison's work include Antibiotic Resistance in Bacteria (51 papers), Infections and bacterial resistance (22 papers) and Bacterial biofilms and quorum sensing (19 papers). Matthew B. Avison is often cited by papers focused on Antibiotic Resistance in Bacteria (51 papers), Infections and bacterial resistance (22 papers) and Bacterial biofilms and quorum sensing (19 papers). Matthew B. Avison collaborates with scholars based in United Kingdom, Thailand and Malaysia. Matthew B. Avison's co-authors include Aki Okazaki, Timothy R. Walsh, J. Maxwell Dow, Lisa Crossman, Safiyh Taghavi, Sébastien Monchy, Robert P. Ryan, Gabriele Berg, Massimiliano Cardinale and Daniël van der Lelie and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.
In The Last Decade
Matthew B. Avison
82 papers receiving 2.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Matthew B. Avison United Kingdom | 28 | 1.4k | 1.2k | 989 | 435 | 341 | 85 | 2.9k | ||
| Karl A. Hassan Australia | 34 | 1.6k 1.2× | 1.4k 1.2× | 674 0.7× | 462 1.1× | 255 0.7× | 85 | 3.6k | ||
| Alejandro M. Viale Argentina | 30 | 1.6k 1.2× | 1.1k 1.0× | 678 0.7× | 536 1.2× | 183 0.5× | 81 | 3.0k | ||
| Francesco Imperi Italy | 37 | 2.3k 1.7× | 1.8k 1.5× | 767 0.8× | 416 1.0× | 265 0.8× | 84 | 4.2k | ||
| Sophie Mangenot France | 24 | 1.3k 0.9× | 749 0.6× | 462 0.5× | 741 1.7× | 168 0.5× | 31 | 2.7k | ||
| Rodolfo García‐Contreras Mexico | 33 | 2.2k 1.6× | 996 0.8× | 622 0.6× | 252 0.6× | 142 0.4× | 97 | 3.6k | ||
| David Vallenet France | 34 | 2.8k 2.0× | 1.0k 0.9× | 686 0.7× | 891 2.0× | 215 0.6× | 62 | 4.8k | ||
| Tung T. Hoang United States | 27 | 3.0k 2.2× | 1.2k 1.0× | 773 0.8× | 495 1.1× | 290 0.9× | 45 | 4.3k | ||
| Lutz Wiehlmann Germany | 32 | 2.2k 1.6× | 1.3k 1.1× | 459 0.5× | 308 0.7× | 186 0.5× | 75 | 3.1k | ||
| Xihui Shen China | 37 | 2.6k 1.9× | 628 0.5× | 1.4k 1.4× | 790 1.8× | 260 0.8× | 166 | 4.7k | ||
| Bart A. Eijkelkamp Australia | 26 | 915 0.7× | 983 0.8× | 494 0.5× | 145 0.3× | 282 0.8× | 55 | 2.2k |
Countries citing papers authored by Matthew B. Avison
Since
Specialization
Citations
This map shows the geographic impact of Matthew B. Avison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Avison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Avison more than expected).
Fields of papers citing papers by Matthew B. Avison
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Matthew B. Avison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Avison. The network helps show where Matthew B. Avison may publish in the future.
Co-authorship network of co-authors of Matthew B. Avison
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Avison. A scholar is included among the top collaborators of Matthew B. Avison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Avison. Matthew B. Avison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Alhusein, Nour, et al.. (2024). The unseen use of antimicrobials: Drivers of human antibiotic use in a community in Thailand and implications for surveillance. Global Public Health. 19(1). 2298940–2298940.
2.
Heesom, Kate J., et al.. (2024). Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays. Antimicrobial Agents and Chemotherapy. 68(7). e0024224–e0024224.
3.
Saunders, Richard J., et al.. (2023). Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at an urban zoo. Journal of Antimicrobial Chemotherapy. 78(7). 1667–1671.
4.
Avison, Matthew B., et al.. (2022). Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam. Antimicrobial Agents and Chemotherapy. 66(4). e0217921–e0217921.
5.
Schubert, H., Jacqueline Findlay, Virginia C. Gould, et al.. (2021). Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region. Journal of Antimicrobial Chemotherapy. 76(12). 3144–3150.
6.
Schubert, H., Jacqueline Findlay, Virginia C. Gould, et al.. (2021). Reduced Antibacterial Drug Resistance and bla CTX-M β-Lactamase Gene Carriage in Cattle-Associated Escherichia coli at Low Temperatures, at Sites Dominated by Older Animals, and on Pastureland: Implications for Surveillance. Applied and Environmental Microbiology. 87(6).
7.
Alorabi, Mohammed, Fergus Hamilton, Yuiko Takebayashi, et al.. (2021). Trade-Offs between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting. Antimicrobial Agents and Chemotherapy. 65(8). e0241220–e0241220.
8.
Schubert, H., et al.. (2021). Factors influencing the detection of antibacterial-resistant Escherichia coli in faecal samples from individual cattle. Journal of Applied Microbiology. 132(4). 2633–2641.
9.
Heesom, Kate J., et al.. (2021). OmpF Downregulation Mediated by Sigma E or OmpR Activation Confers Cefalexin Resistance in Escherichia coli in the Absence of Acquired β-Lactamases. Antimicrobial Agents and Chemotherapy. 65(11). e0100421–e0100421.
10.
Gibbon, Marjorie J., Natacha Couto, Sophia David, et al.. (2021). A high prevalence of bla OXA-48 in Klebsiella (Raoultella) ornithinolytica and related species in hospital wastewater in South West England. Microbial Genomics. 7(3).
11.
Avison, Matthew B., et al.. (2020). Resistance to Ceftazidime/Avibactam plus Meropenem/Vaborbactam When Both Are Used Together Is Achieved in Four Steps in Metallo-β-Lactamase-Negative Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 64(10).
12.
Takebayashi, Yuiko, Jacqueline Findlay, Kate J. Heesom, et al.. (2020). Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) β-lactamase enzymes in Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 76(3). 587–595.
13.
Calvopiña, Karina, et al.. (2020). Novel Mechanisms of Efflux-Mediated Levofloxacin Resistance and Reduced Amikacin Susceptibility in Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy. 65(1).
14.
Findlay, Jacqueline, H. Schubert, Virginia C. Gould, et al.. (2020). Characterization of AmpC-hyperproducing Escherichia coli from humans and dairy farms collected in parallel in the same geographical region. Journal of Antimicrobial Chemotherapy. 75(9). 2471–2479.
15.
Avison, Matthew B., et al.. (2020). Mutation of kvrA Causes OmpK35 and OmpK36 Porin Downregulation and Reduced Meropenem-Vaborbactam Susceptibility in KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 64(7).
16.
Heesom, Kate J., et al.. (2020). Proteomic Investigation of the Signal Transduction Pathways Controlling Colistin Resistance in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 64(8).
17.
Takebayashi, Yuiko, et al.. (2019). CreC Sensor Kinase Activation Enhances Growth of Escherichia coli in the Presence of Cephalosporins and Carbapenems. Antimicrobial Agents and Chemotherapy. 63(11).
18.
Calvopiña, Karina, et al.. (2019). TonB‐dependent uptake of β‐lactam antibiotics in the opportunistic human pathogen Stenotrophomonas maltophilia. Molecular Microbiology. 113(2). 492–503.
19.
Findlay, Jacqueline, et al.. (2019). Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18. Journal of Antimicrobial Chemotherapy. 75(1). 65–71.
20.
Takebayashi, Yuiko, Jacqueline Findlay, Kate J. Heesom, et al.. (2018). Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant Genotypes. Antimicrobial Agents and Chemotherapy. 62(3).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Karl A. Hassan Breakdown of academic impact, for papers by Alejandro M. Viale Breakdown of academic impact, for papers by Francesco Imperi Breakdown of academic impact, for papers by Sophie Mangenot Breakdown of academic impact, for papers by Rodolfo García‐Contreras Breakdown of academic impact, for papers by David Vallenet Breakdown of academic impact, for papers by Tung T. Hoang Breakdown of academic impact, for papers by Lutz Wiehlmann Breakdown of academic impact, for papers by Xihui Shen Breakdown of academic impact, for papers by Bart A. Eijkelkamp